Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial-Reference-Cited by-同舟云学术

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Published:2003-04 Issue:9364 Volume:361 Page:1149-1158
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sever Peter S,Dahlöf Björn,Poulter Neil R,Wedel Hans,Beevers Gareth,Caulfield Mark,Collins Rory,Kjeldsen Sverre E,Kristinsson Arni,McInnes Gordon T,Mehlsen Jesper,Nieminen Markku,O'Brien Eoin,Östergren Jan

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;N Engl J Med,1996

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N Engl J Med,1998

4. The GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study;Athyros;Curr Med Res Opin,2002

5. Intervention Prevention Study (LIPS) Investigators. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomised controlled trial;Serruys;JAMA,2002

Cited by 3132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database;European Stroke Journal;2024-09-10

2. Agreement Between Mega-Trials and Smaller Trials;JAMA Network Open;2024-09-06

3. Review of Recent Literature and Updates in Nonstatin Cholesterol Management;Mayo Clinic Proceedings;2024-09

4. Short‐Term Statin Therapy Induces Hepatic Insulin Resistance Through HNF4α/PAQR9/PPM1α Axis Regulated AKT Phosphorylation;Advanced Science;2024-07-05

5. Cholesterol Lowering in Older Adults: Should We Wait for Further Evidence?;Current Atherosclerosis Reports;2024-07-03